2.5mg semaglutide to tirzepatide vs. for Weight Loss Semaglutide vs. Tirzepatide for Weight

All images are clickable for an enlarged view

Decision matrix Safety considerations researchers should know Both compounds are newer than established GLP-1 agonists , which means their long-term safety profiles are still being characterized

If additional glycemic control is needed after at least 4 weeks on the 1 mg dose: Increase to 2 mg subcutaneously once a week

From the initial consultation to achieving your milestones, we offer the necessary guidance, support, and motivation

Sonja Reichert, an associate professor of family medicine at Western University in London, Ontario, treats and studies obesity and diabetes, and has consulted for makers of weight loss medications

NO eleva ACTH (a diferencia de Hexarelina)